We are live on ! Find out more
ENZ

Enzo Biochem, Inc.
ENZ

Delisted

ENZ was delisted on the 17th of April, 2025.

Back to rankings

85 hedge funds and large institutions have $87.8M invested in Enzo Biochem, Inc. in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,700% more call options, than puts

Call options by funds: $18K | Put options by funds: $1K

12% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 26

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less capital invested

Capital invested by funds: $88.4M → $87.8M (-$663K)

7% less funds holding

Funds holding: 91 → 85 (-6)

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

Holders
85
Holders Change
-6
Holders Change %
-6.59%
% of All Funds
1.84%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
8
Increased
29
Reduced
26
Closed
14
Calls
$18K
Puts
$1K
Net Calls
+$17K
Net Calls Change
+$16K

Top Buyers

Rank Fund Capital Flow
1
HFA
Harbert Fund Advisors
Alabama
+$4.68M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.68M
3
RAM
Roumell Asset Management
Maryland
+$2.6M
4
BCM
Bridgeway Capital Management
Texas
+$871K
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$383K

Top Sellers

Rank Fund Capital Flow
1
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$9.51M
2
CAM
ClariVest Asset Management
California
-$358K
3
BlackRock
BlackRock
New York
-$298K
4
Morgan Stanley
Morgan Stanley
New York
-$295K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$259K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$253K -$16.4K -5,000 -5%
Deutsche Bank
27
Deutsche Bank
Germany
$236K -$130K -39,822 -31%
Los Angeles Capital Management
28
Los Angeles Capital Management
California
$233K -$68.3K -20,860 -20%
Goldman Sachs
29
Goldman Sachs
New York
$231K -$58.6K -17,907 -17%
Assenagon Asset Management
30
Assenagon Asset Management
Luxembourg
$211K +$133K +40,741 +111%
Morgan Stanley
31
Morgan Stanley
New York
$193K -$295K -90,096 -56%
Two Sigma Investments
32
Two Sigma Investments
New York
$189K -$185K -56,398 -45%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$183K – – –
GCP
34
GSA Capital Partners
United Kingdom
$168K -$187 -57 -0.1%
Invesco
35
Invesco
Georgia
$168K +$165K +50,276 +443%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$162K -$3.78K -1,155 -2%
Citadel Advisors
37
Citadel Advisors
Florida
$158K -$15.3K -4,683 -8%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$155K – – –
Bank of America
39
Bank of America
North Carolina
$139K -$55.1K -16,840 -25%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$111K – – –
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$96K -$9.51M -2,904,182 -99%
AllianceBernstein
42
AllianceBernstein
Tennessee
$88K – – –
PPA
43
Parametric Portfolio Associates
Washington
$84K +$51.3K +15,662 +104%
RJT
44
Raymond James Trust
Florida
$82K – – –
AIG
45
American International Group
New York
$77K -$2.98K -910 -3%
SEI Investments
46
SEI Investments
Pennsylvania
$66K – – –
EGM
47
Engineers Gate Manager
New York
$66K +$17.1K +5,216 +27%
Neuberger Berman Group
48
Neuberger Berman Group
New York
$62K – – –
State Board of Administration of Florida Retirement System
49
State Board of Administration of Florida Retirement System
Florida
$55K – – –
VOYA Investment Management
50
VOYA Investment Management
Georgia
$55K – – –
1
2
3 4

ENZ Hedge Fund Activity: Q1 2019 in Review

85 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q1 2019, worth a combined $87.8M — down 0.75% from $88.4M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of ENZ and 8 opened new positions — a net loss of 6 holders — while 26 trimmed existing stakes and 29 added.

The largest buyer was Harbert Fund Advisors, adding an estimated $4.68M. The largest seller was Manulife (Manufacturers Life Insurance), cutting an estimated $9.51M.

  • 85 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q1 2019, down from 91 in Q4 2018.
  • Funds reported $87.8M of Enzo Biochem, Inc. stock for Q1 2019, down 0.75% quarter-over-quarter.
  • 8 funds opened new Enzo Biochem, Inc. positions in Q1 2019 and 14 closed out, a net change of -6 holders.
  • The largest Enzo Biochem, Inc. buyer in Q1 2019 was Harbert Fund Advisors, an estimated $4.68M added.
  • The largest Enzo Biochem, Inc. seller in Q1 2019 was Manulife (Manufacturers Life Insurance), an estimated $9.51M sold.

Based on aggregated 13F filings for Q1 2019.